ProPublica Sued the FDA for Withholding Records About Drug Safety — ProPublica

Propublic has sued the United States drug and food administration in a federal court in New York, accusing the agency to retain information on the security and availability of critical generic drugs for millions of Americans.

For years, Congress, surveillance groups, doctors and others have questioned the quality of generic drugs made in factories abroad. To better understand how the FDA regulates the industry and protects consumers, Propublic submitted four records of records last year under the Freedom of Information Law.

The FDA refused to quickly publish the documents, including the records that would make drugs made in some of the most problematic factories in India. The inspection reports that describe the insecure manufacturing conditions are public, but the FDA builds the names of the medications made in those factories.

“Americans (including pharmacists, doctors, hospital systems, political leaders) cannot see for themselves what medications may have been done in insecure facilities,” said the demand.

Propublic requested records as part of an investment of incorporation in the security of the generic supply of drugs in the United States. Propublic has reported that the FDA allowed some manufacturers to continue sending their drugs to Americans just after the factories that made them find the violation of quality standards and prohibited in the US market. More than 150 drugs or their ingredients received these little known exemptions in the past boxes of years.

In his response to the application for initial propublicic records, the FDA said that the news organization had not demonstrated “a convincing need” to accelerate the publication of documents. Since the demand was filed in November, the agency has begun to activate some of the requested records. The case is still active in a federal court in New York.

Propublic has argued that records will help inform American consumers, who depend more and more generic drugs made abroad. Quality concerns have pursued the industry for years: in 2023, four people died after using contaminated eye drops made in India, and others had to eliminate their surgically ocular balloons.

“Each of us depends on the FDA to ensure that the medications that we take and renounce loved ones are safe,” said propublicic lawyer Jack Browning, a partner of Davis Wright Tremaine. “With the growing prevalence of manufacturing on the high seas, it is imperative that organizations such as Propublic guarantee that safety violations are not swept under the carpet.”

The Department of Health and Human Services, which supervises the FDA, declined to comment on the case, citing the undo litigation.

This is the second time that propublic demands the FDA in recent years.

In 2023, the media and the Pittsburgh Post-Gazette filed a lawsuit against the agency to retain records related to the massive withdrawal of the breathing machines made by PHILIPS A this. The agency finally provides the documents.